Schriftzug
Mittwoch, 17.02.2021 19:25 von | Aufrufe: 218

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PTVCA, AEGN, CATM, CHNG, GWPH, PS, SNCA

Schriftzug "News" (Symbolbild). pixabay.com

PR Newswire

NEW YORK, Feb. 17, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Protective Insurance Corporation (NASDAQ: PTVCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to The Progressive Corporation for $23.30 in cash for each share of Protective Class A and Class B common stock. If you are a Protective shareholder, click here to learn more about your rights and options.  

Aegion Corporation (NASDAQ: AEGN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to affiliates of New Mountain Capital, L.L.C for $26.00 per share in cash. If you are an Aegion shareholder, click here to learn more about your rights and options.  

Cardtronics plc (NASDAQ: CATM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to NCR Corporation for $39.00 per share in cash. If you are a Cardtronics shareholder, click here to learn more about your rights and options.

Change Healthcare Inc. (NASDAQ: CHNG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Optum, a company that is part of UnitedHealth Group. Under the merger agreement, Change Healthcare shareholders will receive $25.75 per share in cash. If you are a Change Healthcare shareholder, click here to learn more about your rights and options.

GW Pharmaceuticals plc (NASDAQ: GWPH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Jazz Pharmaceuticals plc for $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS). If you are a GW Pharmaceuticals shareholder, click here to learn more about your rights and options. 


ARIVA.DE Börsen-Geflüster

Pluralsight, Inc. (NASDAQ: PS) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Vista Equity Partners for $20.26 per share. If you are a Pluralsight shareholder, click here to learn more about your rights and options.

Seneca Biopharma, Inc. (NASDAQ: SNCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Leading BioSciences, Inc. If you are a Seneca shareholder, click here to learn more about your rights and options.  

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com 
zhalper@halpersadeh.com 
https://www.halpersadeh.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-investigates-the-following-companies-on-behalf-of-shareholders--ptvca-aegn-catm-chng-gwph-ps-snca-301230148.html

SOURCE Halper Sadeh LLP

Werbung

Mehr Nachrichten zur Aegion Corp Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.